Glooko
Private Company
Total funding raised: $88.5M
Overview
Glooko is a US-based digital health company, founded in 2010, that provides a unified data management platform for diabetes care. The platform aggregates and visualizes data from over 200 compatible diabetes and health monitoring devices, enabling remote patient monitoring and data-driven clinical decisions. It targets two main customer segments: healthcare providers seeking to streamline clinical workflows and patients aiming to better understand and manage their condition. The company is committed to high standards of data security and regulatory compliance, including CE Marking as a Class IIa medical device and adherence to GDPR and ISO 27001.
Technology Platform
A cloud-based data aggregation and analytics platform that syncs with over 200 compatible diabetes and health monitoring devices (glucose meters, CGMs, insulin pumps, smart pens, fitness trackers). It provides unified data visualization, remote patient monitoring tools, and integrates into clinical workflows for healthcare providers.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Glooko competes in a crowded digital diabetes management space. Direct competitors include other data aggregation platforms like Tidepool and mySugr. It also faces competition from device-centric ecosystems from major CGM and pump manufacturers (Dexcom Clarity, Abbott LibreView, Tandem t:connect), and potential competition from broad health data platforms from large technology firms. Its key differentiator is its extensive, device-agnostic compatibility.